Predictors of Crimean-Congo hemorrhagic fever in the Emergency Department

Erenler A. K., Kulaksiz F., Ulger H., Capraz M., Tomak L., Baydin A.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, vol.19, no.20, pp.3811-3816, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 19 Issue: 20
  • Publication Date: 2015
  • Journal Name: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.3811-3816
  • Keywords: Emergency Department, Tick bite, Laboratory findings, Fatality rate, CLINICAL-FEATURES, RIBAVIRIN THERAPY, ORAL RIBAVIRIN, TICK SURVEY, VIRUS, TURKEY, EFFICACY, OUTBREAK, DISEASE, AFRICA
  • Ondokuz Mayıs University Affiliated: Yes

Abstract

OBJECTIVE: Crimean-Congo hemorrhagic fever (CCHF) is an acute illness affecting multiple organ systems characterized by thrombocytopenia, and/or leukopenia, elevated levels of alanine aminotranferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH) and creatine kinase (CK) and it has a case-fatality of 8% to 80%. In this article, we aimed to determine the clinical and laboratory findings that predicts the disease on admission.